2008
DOI: 10.1248/cpb.56.831
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis and Cytotoxicity of Novel Podophyllotoxin Derivatives

Abstract: A series of novel podophyllotoxin derivatives were designed using association strategy and synthesized by coupling either podophyllotoxin (1) or 4b b-amino podophyllotoxin (3) with substituted indol-3-yl-glyoxyl chlorides. Their structures were identified using spectroscopic techniques. These novel derivatives have been evaluated for cytotoxicity in vitro against four human cancer cell lines with comparison to the parent compounds 1, 3 and indibulin (2). Some of the compounds (7a, 7c) showed comparable cytotox… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
18
0
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 31 publications
(19 citation statements)
references
References 10 publications
0
18
0
1
Order By: Relevance
“…N-Substituted 5-formylindoles (2a-h) were synthesized by the literature method [10]. General Procedure for the Synthesis of 5a-q.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…N-Substituted 5-formylindoles (2a-h) were synthesized by the literature method [10]. General Procedure for the Synthesis of 5a-q.…”
Section: Methodsmentioning
confidence: 99%
“…Furthermore, indibulin lacks the neurotoxicity typically associated with other tubulin-binding drugs such as the taxanes and vinca alkaloids, which might be related to its unknown tubulin-binding mode [9]. Both podophyllotoxin and indibulin are potent microtubulin inhibitors, but the indibulinbinding sites of the two compounds are different [10]. This prompted us to design hybrids of indibulin and podophyllotoxin with the aim of discovering novel tubulin inhibitors that can lower podophyllotoxincs toxicity by binding to a novel tubulinbinding domain.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…However, utility of PPT as an antitumor drug encountered a lot of restrictions because of its toxicity [3] . Recently, efforts are made to develop new derivatives or dosage forms of PPT with optimized curative effect and attenuated toxicity [4,5] . In previous researches, we carried out deep investigations about the antitumor mechanism of PPT and its derivatives [6−8] .…”
Section: Introductionmentioning
confidence: 99%